Ilisa Bernstein's Letter to the FDA Regarding Pharmacists Prescribing Oral COVID-19 Treatments Ilisa Bernstein's Letter to the FDA Regarding Pharmacists Prescribing Oral COVID-19 Treatments A letter from Interim CEO Ilisa Bernstein, PharmD, JD, FAPhA, to Dr. Robert Califf, Commissioner of the Food and Drug Administration (FDA), on the importance of pharmacists being allowed to prescribe oral COVID-19 treatments.
Your Voice, Our Mission! Your Voice, Our Mission! Hear from Ilisa BG Bernstein, PharmD, JD, FAPhA, APhA’s new interim executive vice president and CEO, about her background and history with APhA as well as our top strategic priorities, which will propel us to move the profession forward.